The World Orphan Drug Congress Europe returns 27-29 October 2025 as the
largest and most established orphan drug & rare disease meeting of its kind!
From cell and gene therapy, genetic testing, and market access, to real world evidence, this one meeting covers the whole orphan drugs value chain where science, government and manufacturers all come together to create groundbreaking progress.
Limited FREE passes
are available for Takeda employees in Belgium and Netherlands, granting full access to the conference, including the workshop day, networking app and drink receptions.
Please note: all applications are subject to Terrapinn approval and availability. We also have the right to decline or withdraw your application at any time.
Takeda will be contributing sessions across the
entire programme
– see who will be speaking below:
28 October
09:10
Toon Digneffe
Head Public Affairs & Public Policy, Takeda & Chair, EUCOPE Incentives Steering Group and EUCOPE Board member
Keynote panel: Looking ahead, what does the future hold for Europe’s Life Science Strategy and what does it mean for rare diseases?
10:00
Jon Neal
Head of Central, South and Eastern Europe, Takeda & Member of the EFPIA European Markets Committee
Keynote panel: How well has your EUHTA implementation gone?
Offer applies to Takeda employees only. All guest pass applications subject to Terrapinn approval.
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events